These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 31732529)
1. Early Protection against Pertussis Induced by Live Attenuated Debrie AS; Mielcarek N; Lecher S; Roux X; Sirard JC; Locht C J Immunol; 2019 Dec; 203(12):3293-3300. PubMed ID: 31732529 [TBL] [Abstract][Full Text] [Related]
2. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3. Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898 [TBL] [Abstract][Full Text] [Related]
3. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998 [TBL] [Abstract][Full Text] [Related]
4. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. Skerry CM; Mahon BP Clin Vaccine Immunol; 2011 Feb; 18(2):187-93. PubMed ID: 21147936 [TBL] [Abstract][Full Text] [Related]
6. Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate. Lim A; Ng JK; Locht C; Alonso S Microbes Infect; 2014 Jan; 16(1):51-60. PubMed ID: 24140230 [TBL] [Abstract][Full Text] [Related]
7. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. Kavanagh H; Noone C; Cahill E; English K; Locht C; Mahon BP Clin Exp Allergy; 2010 Jun; 40(6):933-41. PubMed ID: 20184606 [TBL] [Abstract][Full Text] [Related]
8. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice. Feunou PF; Kammoun H; Debrie AS; Locht C Vaccine; 2014 Jul; 32(34):4281-8. PubMed ID: 24950361 [TBL] [Abstract][Full Text] [Related]
10. Attenuated Bordetella pertussis BPZE1 protects against allergic airway inflammation and contact dermatitis in mouse models. Li R; Cheng C; Chong SZ; Lim AR; Goh YF; Locht C; Kemeny DM; Angeli V; Wong WS; Alonso S Allergy; 2012 Oct; 67(10):1250-8. PubMed ID: 22909095 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. Jahnmatz M; Richert L; Al-Tawil N; Storsaeter J; Colin C; Bauduin C; Thalen M; Solovay K; Rubin K; Mielcarek N; Thorstensson R; Locht C; Lancet Infect Dis; 2020 Nov; 20(11):1290-1301. PubMed ID: 32687804 [TBL] [Abstract][Full Text] [Related]
12. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. Thorstensson R; Trollfors B; Al-Tawil N; Jahnmatz M; Bergström J; Ljungman M; Törner A; Wehlin L; Van Broekhoven A; Bosman F; Debrie AS; Mielcarek N; Locht C PLoS One; 2014; 9(1):e83449. PubMed ID: 24421886 [TBL] [Abstract][Full Text] [Related]
13. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C Vaccine; 2012 Aug; 30(40):5864-70. PubMed ID: 22814407 [TBL] [Abstract][Full Text] [Related]
14. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route. Li R; Lim A; Alonso S Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832 [TBL] [Abstract][Full Text] [Related]
15. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiodi F; Mielcarek N; Locht C; Thorstensson R Vaccine; 2014 Jun; 32(27):3350-6. PubMed ID: 24793938 [TBL] [Abstract][Full Text] [Related]
16. Non-specific Effects of Live Attenuated Pertussis Vaccine Against Heterologous Infectious and Inflammatory Diseases. Cauchi S; Locht C Front Immunol; 2018; 9():2872. PubMed ID: 30581436 [No Abstract] [Full Text] [Related]
17. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. Lin A; Apostolovic D; Jahnmatz M; Liang F; Ols S; Tecleab T; Wu C; van Hage M; Solovay K; Rubin K; Locht C; Thorstensson R; Thalen M; Loré K J Clin Invest; 2020 May; 130(5):2332-2346. PubMed ID: 31945015 [TBL] [Abstract][Full Text] [Related]
18. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Skerry CM; Cassidy JP; English K; Feunou-Feunou P; Locht C; Mahon BP Clin Vaccine Immunol; 2009 Sep; 16(9):1344-51. PubMed ID: 19625486 [TBL] [Abstract][Full Text] [Related]
19. Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection. Locht C; Papin JF; Lecher S; Debrie AS; Thalen M; Solovay K; Rubin K; Mielcarek N J Infect Dis; 2017 Jul; 216(1):117-124. PubMed ID: 28535276 [TBL] [Abstract][Full Text] [Related]
20. The Role of Mucosal Immunity in Pertussis. Solans L; Locht C Front Immunol; 2018; 9():3068. PubMed ID: 30692990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]